Dear Colleagues and Friends,
We cordially invite you to the 14th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2024) annual conference, which will be held on July 18-20, 2024, in Honolulu, Hawaii. It is our pleasure to be hosting the forthcoming meeting in person for the first time ever in the United States.
The APPLE Association is a professional organization dedicated to the research, prevention, and treatment of primary liver cancer in the Asia-Pacific region. We will continue to foster and promote the intellectual collaboration and exchange among physicians, scientists, and industry leaders for sharing valuable research results for the treatment of liver cancer and discussion pertaining to the latest advancements in liver diagnosis and care.
Internationally known experts in the field of liver cancer will be invited to this meeting to have discussions on the following:
- Molecular pathogenesis and pathology of hepatocellular carcinoma (HCC)
- Surgery and liver transplantation for HCC
- Locoregional therapy for HCC (including combination with systemic therapy)
- Systemic therapy including immunotherapy, tyrosine kinase inhibitors and more, for advanced HCC
- Intrahepatic cholangiocarcinoma
- Fibrolamellar carcinoma
Don’t miss the exclusive opportunity to collaborate, learn, and share the latest advancements and findings in the field of liver cancer with distinguished scholars and experts to develop solutions to the most pressing issues today and beyond.
Thank you, and we look forward to seeing you in Honolulu!
Yours sincerely,
Ghassan Abou-Alfa, MD, MBA Attending Physician Memorial Sloan Kettering Cancer Center Professor Weill Cornell Medical College at Cornell University New York, NY, USA |
Linda L. Wong, MD Associate Member, Cancer Biology University of Hawai’i Cancer Center Director, Liver Transplant Program The Queen’s Medical Center Honolulu, HI, USA |

Ghassan Abou-Alfa, MD, MBA
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College at Cornell University
New York, NY, USA

Linda L. Wong, MD
Associate Member, Cancer Biology
University of Hawai’i Cancer Center
Director, Liver Transplant Program
The Queen’s Medical Center
Honolulu, HI, USA

Medical Crossfire®: Individualizing Treatment Plans in Advanced Hepatocellular Carcinoma Based on Biology and Other Patient Characteristics
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 15.0 contact hours.
Click here to submit an abstract 14th Annual Asia-Pacific Primary Liver Cancer Expert Meeting.
Submission Deadline is April 30, 2024 11:59 PM HAT






